Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SE
326
DELISTED
Spectra Energy Corp Wi
SE
| $40.3M | 0.08% |
+1,234,864
| New | +$44M |
|
|
ATHN
327
DELISTED
Athenahealth, Inc.
ATHN
| $40.2M | 0.08% |
351,238
+121,272
| +53% | +$14.5M |
|
328
Evercore
EVR
$11.2B
| $40.2M | 0.08% |
744,093
-151,927
| -17% | -$7.75M |
|
329
Alibaba
BABA
$286B
| $40.1M | 0.08% |
487,477
+392,533
| +413% | +$33.7M |
|
|
PDCO
330
DELISTED
Patterson Companies, Inc.
PDCO
| $40.1M | 0.08% |
824,361
+775,362
| +1,582% | +$37M |
|
331
GE Aerospace
GE
$361B
| $40.1M | 0.08% |
+314,869
| New | +$40.8M |
|
332
Bio-Rad Laboratories Class A
BIO
$10.2B
| $40.1M | 0.08% |
266,121
-31,803
| -11% | -$4.55M |
|
333
DexCom
DXCM
$34.8B
| $39.9M | 0.08% |
1,994,488
-1,476,176
| -43% | -$25.9M |
|
334
Carnival Corporation Ltd
CCL
$35.2B
| $39.5M | 0.07% |
799,306
+447,626
| +127% | +$21.1M |
|
335
Vipshop
VIPS
$6.98B
| $39.3M | 0.07% |
1,764,824
+757,831
| +75% | +$20.1M |
|
336
Keurig Dr Pepper
KDP
$43.6B
| $39.2M | 0.07% |
537,212
-25,244
| -4% | -$1.93M |
|
337
Incyte
INCY
$25.9B
| $39.1M | 0.07% |
375,628
+104,270
| +38% | +$10.8M |
|
|
TWO
338
Two Harbors Investment
TWO
$1.27B
| $38.8M | 0.07% |
497,458
+147,671
| +42% | +$12.4M |
|
339
Prologis
PLD
$135B
| $38.7M | 0.07% |
+1,043,793
| New | +$42.5M |
|
|
BHI
340
DELISTED
Baker Hughes
BHI
| $38.6M | 0.07% |
626,244
-1,690,620
| -73% | -$111M |
|
341
Range Resources
RRC
$9.59B
| $38.6M | 0.07% |
+781,865
| New | +$44.6M |
|
342
Pacira BioSciences
PCRX
$983M
| $38.6M | 0.07% |
545,570
+465,661
| +583% | +$36.7M |
|
343
Labcorp
LH
$27.3B
| $38.6M | 0.07% |
370,437
+82,084
| +28% | +$8.54M |
|
344
Enbridge
ENB
$110B
| $38.4M | 0.07% |
821,023
+706,204
| +615% | +$35.1M |
|
345
News Corp Class A
NWSA
$16.4B
| $38.4M | 0.07% |
2,631,092
-511,784
| -16% | -$7.86M |
|
346
SunCoke Energy
SXC
$822M
| $38.3M | 0.07% |
2,948,813
+658,809
| +29% | +$10.4M |
|
347
Lear
LEA
$8.56B
| $38.1M | 0.07% |
339,811
-160,583
| -32% | -$18.4M |
|
|
TXNM
348
TXNM Energy Inc
TXNM
$5.9B
| $38.1M | 0.07% |
1,548,817
+655,310
| +73% | +$17.5M |
|
349
Regions Financial
RF
$25.9B
| $38M | 0.07% |
3,664,560
-673,952
| -16% | -$6.79M |
|
350
Dover
DOV
$27.2B
| $37.8M | 0.07% |
667,335
+5,963
| +0.9% | +$355K |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.